07:00 , Apr 24, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Gaucher's disease Glucosidase-b bile acid 2 (GBA2) Mouse studies suggest inhibiting GBA2 could help treat type 1 Gaucher's disease. In a mouse model of...